journal article·2020-02

Effects of hydroxyl radicals produced by a zinc phthalocyanine photosensitizer on tumor DNA

Shufeng Yan, Hanhan Guo, Jianqiang Su, Jincan Chen, Xiaorong Song, Mingdong Huang, Juncheng Zhang, Zhuo Chen

Dyes and Pigments· Volume 173
Publisher page

Abstract

Abstract Photodynamic therapy (PDT) is a new therapeutic approach for cancer treatment. Its mechanism relies on three elements: photosensitizer, light and oxygen. Under aerobic conditions, a suitable wavelength of light activates the photosensitizer that results in the formation of reactive oxygen species (ROS). We herein report that PDT with a zinc phthalocyanine (ZnPc) photosensitizer coupled with 2,4,6-tris (N, N-dimethylaminomethyl) phenoxy (TAP), termed as ZnPc(TAP)4, has the ability to photodegrade DNA in tumor cells via hydroxyl radicals produced under the red light irradiation, resulting in effective elimination of tumor cells. Furthermore, the high-efficient anti-tumor effect of ZnPc(TAP)4 was verified in a human breast adenocarcinoma cell line MCF-7 tumor-bearing animal model. To the best of our knowledge, this is the first time that destructive effects of hydroxyl radicals produced by PDT on DNA of tumor cells has been documented, which may open up new avenues of antitumor therapy on eliminating the DNA of tumor cells.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Cancer statistics, 2017
2. Global cancer statistics
3. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse10.1158/2159-8290.CD-16-0241 ↗
4. Indication for surgical resection in patients with hepatocellular carcinoma with major vascular invasion, Biosci
5. Therapy, anthracycline chemotherapy and cardiotoxicity10.1007/s10557-016-6711-0 ↗
6. Plk1 inhibitors in cancer therapy: from laboratory to clinics10.1158/1535-7163.MCT-15-0897 ↗
7. SWCNTs as novel theranostic nanocarriers for cancer diagnosis and therapy: towards safe translation to the clinics10.2217/nnm-2016-0065 ↗
8. Targeting mutant p53 for efficient cancer therapy10.1038/nrc.2017.109 ↗
9. Double-stranded DNA in exosomes: a novel biomarker in cancer detection10.1038/cr.2014.44 ↗
10. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer10.1074/jbc.C113.532267 ↗
11. Biological role of cell-free nucleic acids in cancer: the theory of genometastasis10.1615/CritRevOncog.v18.i1-2.90 ↗
12. Horizontal transfer of oncogenes by uptake of apoptotic bodies10.1073/pnas.101129998 ↗
13. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy10.1158/2159-8290.CD-15-1483 ↗
14. Action of deoxyribonuclease and ribonuclease on the growth of Ehrlich ascites carcinoma in mice10.1038/192052a0 ↗
15. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells10.1158/0008-5472.CAN-09-3513 ↗
16. Cell-free nucleic acids as biomarkers in cancer patients10.1038/nrc3066 ↗
17. Photodynamic therapy of cancer: an update
18. Afterglow properties of CaF2:Tm nanoparticles and its potential application in photodynamic therapy10.1016/j.jlumin.2015.11.043 ↗
19. Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles10.1016/j.jcis.2017.10.030 ↗
20. Benzyl ester dendrimer silicon phthalocyanine based polymeric nanoparticle for in vitro photodynamic therapy of glioma10.1016/j.jlumin.2018.12.012 ↗
21. Oncologic photodynamic therapy: basic principles, current clinical status and future directions10.3390/cancers9020019 ↗
22. Photodynamic therapy: past, present and future10.1002/tcr.201600121 ↗
23. Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer10.1007/s10103-012-1248-3 ↗
24. Photodynamic therapy: inception to application in breast cancer10.1016/j.breast.2016.09.016 ↗
25. Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms10.1038/srep44497 ↗
26. Cancer tissue classification, associated therapeutic implications and PDT as an alternative
27. Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma10.1016/j.biomaterials.2014.07.001 ↗
28. Sinica, research progress on the phthalocyanine based targeting photosensitizers in photodynamic therapy10.6023/A16100553 ↗
29. A dual-targeted nucleic acid moiety decorated SPION nanoparticles for chemo-photodynamic synergistic therapy10.1016/j.jlumin.2019.02.019 ↗
30. Therapeutics, in vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects10.4103/0973-1482.87035 ↗
31. Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-alkylpyridylporphyrins10.1074/jbc.M113.511642 ↗
32. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine10.1021/bc3002997 ↗
33. Rapid killing of bacteria by a new type of photosensitizer10.1007/s00253-017-8133-8 ↗
34. The water soluble peripherally tetra-substituted zinc(II), manganese(III) and copper(II) phthalocyanines as new potential anticancer agents10.1039/C6DT02720B ↗
35. Synthesis, DNA-binding study, and antioxidant activity of 14-aryl-14H-dibenzo[a,j]xanthene derivatives10.1007/s00044-014-1124-8 ↗
36. Synthesis, structure and interactions with DNA of novel tetranuclear, [Mn-4(II/II/II/IV)] mixed valence complexes10.1016/j.jinorgbio.2007.10.005 ↗